Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

801
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
801

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score.

Journal of clinical medicine·2026
Same author

Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study.

Journal of clinical medicine·2026
Same author

Hypervolemia was associated with hypertension and endothelial dysfunction in kidney transplant recipients.

The International journal of artificial organs·2026
Same author

Diagnostic Utility of Serum Activating Transcription Factor 4 and Toll-like Receptor 4 as Early Biomarkers of Inflammation in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal of clinical medicine·2026
Same author

The Importance of Serum Perilipin-2 Level as an Early Indicator of Inflammation in Non-Alcoholic Fatty Liver Disease.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 12, 2026

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

6.2K

Interferon Induced Focal Segmental Glomerulosclerosis.

Yusuf Kayar1, Nuket Bayram Kayar2, Nadir Alpay3

  • 1Department of Internal Medicine, Bezmialem Vakif University, Istanbul, Turkey.

Case Reports in Nephrology
|November 17, 2016
PubMed
Summary

Behçet's disease patients treated with interferon-alpha may develop focal segmental glomerulosclerosis (FSGS), a kidney condition. This case highlights the potential renal side effects of interferon therapy in Behçet's patients.

More Related Videos

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

9.8K
Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.2K

Related Experiment Videos

Last Updated: Mar 12, 2026

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
06:39

Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation

Published on: August 19, 2020

6.2K
Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection
09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

9.8K
Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

14.2K

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Behçet's disease is a multisystem inflammatory disorder of unknown cause.
  • Focal segmental glomerulosclerosis (FSGS) is a kidney disease often linked to infections, immune issues, or certain therapies.
  • Interferon therapy is used for conditions like uveitis, which can occur in Behçet's disease.

Purpose of the Study:

  • To report a case of FSGS in a patient with Behçet's disease.
  • To investigate the potential link between interferon-alpha treatment and FSGS development.
  • To highlight renal complications associated with interferon therapy.

Main Methods:

  • A kidney biopsy was performed to diagnose FSGS.
  • Clinical presentation of acute renal failure and nephrotic syndrome was documented.
  • Patient history of Behçet's disease and interferon-alpha treatment was reviewed.

Main Results:

  • The patient, diagnosed with Behçet's disease and treated with interferon-alpha for uveitis, developed FSGS.
  • Kidney biopsy confirmed FSGS in the context of acute renal failure and nephrotic syndrome.
  • The findings suggest a possible association between interferon-alpha and FSGS in this patient.

Conclusions:

  • Interferon-alpha therapy may induce FSGS in patients with Behçet's disease.
  • Physicians should monitor renal function in Behçet's patients undergoing interferon treatment.
  • FSGS is a potential adverse effect of interferon therapy, particularly in autoimmune conditions.